Severe Androgenetic Alopecia as a Marker of Metabolic Syndrome in Male Patients: A Hospital-Based Case Control Study

In a 2017 hospital-based case control study involving 100 male patients with androgenetic alopecia (AGA), researchers found a significant association between severe AGA and metabolic syndrome (MS). The study, which included a control group of age and sex-matched individuals, revealed that MS was 4.6 times more common in patients with AGA compared to the control group. Furthermore, MS was significantly more prevalent in patients with severe AGA compared to those with mild-moderate AGA. Among the evaluated parameters of MS, such as blood pressure, fasting blood sugar, and dyslipidemia, all were significantly more common in AGA patients compared to controls, except for abdominal obesity. The findings suggest that patients with severe AGA are at a higher risk of developing MS and other cardiovascular diseases.